NeuroDerm Ltd. Ordinary Shares
NDRM
NDRM was delisted on the 17th of October, 2017.
50 hedge funds and large institutions have $171M invested in NeuroDerm Ltd. Ordinary Shares in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 5 closing their positions.
13% more capital invested
Capital invested by funds: $151M → $171M (+$20.1M)
0% more funds holding
Funds holding: 50 → 50 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $518K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.8M |
| 2 |
GTC
Ghost Tree Capital
New York
|
+$2.27M |
| 3 |
NC
Nexthera Capital
New York
|
+$2.27M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$2.24M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$1.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$7.71M |
| 2 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$3.27M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.96M |
| 4 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$1.35M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$425K |
NDRM Hedge Fund Activity: Q3 2016 in Review
50 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q3 2016, worth a combined $171M — up 13% from $151M a quarter earlier.
Fund positioning in NDRM was balanced in Q3 2016: 5 funds opened new positions, 5 closed out, 15 added to existing stakes and 16 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $4.8M. The largest seller was GMT Capital, cutting an estimated $7.71M.
- 50 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $171M of NeuroDerm Ltd. Ordinary Shares stock for Q3 2016, up 13% quarter-over-quarter.
- 5 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q3 2016 and 5 closed out, a net change of 0 holders.
- The largest NeuroDerm Ltd. Ordinary Shares buyer in Q3 2016 was Adage Capital Partners, an estimated $4.8M added.
- The largest NeuroDerm Ltd. Ordinary Shares seller in Q3 2016 was GMT Capital, an estimated $7.71M sold.
Based on aggregated 13F filings for Q3 2016.